
Oligodendrocyte‑Targeted Gene Therapy Shows Breakthrough Potential in Canavan Disease
As reported on InsidePrecisionMedicine, a new gene therapy aimed directly at the cells responsible for myelination is showing unprecedented promise for children with Canavan disease,




